CERIMON PHARMACEUTICALS RAISES $70 MILLION IN SERIES A FINANCING
Cerimon Pharmaceuticals announced today the completion of a $70 million Series A financing, which will be used to expand the Company's product pipeline through innovative partnering transactions and product acquisitions. The financing was led by MPM Capital, together with Nomura Phase4 Ventures and OrbiMed Advisors. Cerimon also announced separately today that it has acquired U.S. rights to market and sell two topical formulations of diclofenac, a non-steroidal anti-inflammatory drug (NSAID).
dBusinessNews San Francisco (http://sanfrancisco.dbusinessnews.com/shownews.php?newsid=48966&type_news=latest)